ATE216266T1 - Einen liganden enthaltendes arzneimittel zur behandlung und/oder diagnose von weichgeweben- tumoren - Google Patents
Einen liganden enthaltendes arzneimittel zur behandlung und/oder diagnose von weichgeweben- tumorenInfo
- Publication number
- ATE216266T1 ATE216266T1 AT92101569T AT92101569T ATE216266T1 AT E216266 T1 ATE216266 T1 AT E216266T1 AT 92101569 T AT92101569 T AT 92101569T AT 92101569 T AT92101569 T AT 92101569T AT E216266 T1 ATE216266 T1 AT E216266T1
- Authority
- AT
- Austria
- Prior art keywords
- treatment
- ligand
- diagnosis
- soft tissue
- product containing
- Prior art date
Links
- 206010068771 Soft tissue neoplasm Diseases 0.000 title 1
- 238000003745 diagnosis Methods 0.000 title 1
- 239000003446 ligand Substances 0.000 title 1
- 229940126601 medicinal product Drugs 0.000 title 1
- URDCARMUOSMFFI-UHFFFAOYSA-N 2-[2-[bis(carboxymethyl)amino]ethyl-(2-hydroxyethyl)amino]acetic acid Chemical compound OCCN(CC(O)=O)CCN(CC(O)=O)CC(O)=O URDCARMUOSMFFI-UHFFFAOYSA-N 0.000 abstract 1
- 201000009030 Carcinoma Diseases 0.000 abstract 1
- 241000124008 Mammalia Species 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 238000009472 formulation Methods 0.000 abstract 1
- 229910052751 metal Inorganic materials 0.000 abstract 1
- 239000002184 metal Substances 0.000 abstract 1
- 150000002739 metals Chemical class 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/0474—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group
- A61K51/0478—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group complexes from non-cyclic ligands, e.g. EDTA, MAG3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2121/00—Preparations for use in therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2123/00—Preparations for testing in vivo
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Physics & Mathematics (AREA)
- Optics & Photonics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Solid-Sorbent Or Filter-Aiding Compositions (AREA)
- Electroluminescent Light Sources (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US07/648,663 US5308606A (en) | 1991-01-30 | 1991-01-30 | Method of treating and/or diagnosing soft tissue tumors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE216266T1 true ATE216266T1 (de) | 2002-05-15 |
Family
ID=24601702
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT92101569T ATE216266T1 (de) | 1991-01-30 | 1992-01-30 | Einen liganden enthaltendes arzneimittel zur behandlung und/oder diagnose von weichgeweben- tumoren |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US5308606A (forum.php) |
| EP (1) | EP0499098B1 (forum.php) |
| JP (1) | JPH05505629A (forum.php) |
| KR (1) | KR100219965B1 (forum.php) |
| AT (1) | ATE216266T1 (forum.php) |
| AU (1) | AU650944B2 (forum.php) |
| CA (1) | CA2060332A1 (forum.php) |
| DE (1) | DE69232554T2 (forum.php) |
| FI (1) | FI924363L (forum.php) |
| IE (1) | IE920311A1 (forum.php) |
| IL (1) | IL100800A (forum.php) |
| MX (1) | MX9200413A (forum.php) |
| NZ (1) | NZ241463A (forum.php) |
| SG (1) | SG45366A1 (forum.php) |
| TW (1) | TW205509B (forum.php) |
| WO (1) | WO1992013571A1 (forum.php) |
| ZA (1) | ZA92663B (forum.php) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5739313A (en) * | 1995-11-13 | 1998-04-14 | Regents Of The University Of Minnesota | Radionuclide labeling of vitamin B12 and coenzymes thereof |
| US6806363B1 (en) * | 1999-04-16 | 2004-10-19 | Mayo Foundation For Medical Education & Research | Cobalamin conjugates useful as antitumor agents |
| MXPA02003772A (es) | 1999-10-15 | 2005-04-28 | Mayo Foundation | Conjugados de cobalamina, utiles como agentes para obtencion de imagen y como agentes terapeuticos. |
| EP1231942A1 (en) * | 1999-10-15 | 2002-08-21 | Mayo Foundation For Medical Education And Research | Cobalamin conjugates useful as imaging agents and as antitumor agents |
| US7591995B2 (en) * | 1999-10-15 | 2009-09-22 | Mayo Foundation For Medical Education And Research | Cobalamin conjugates useful as imaging and therapeutic agents |
| CA2427146A1 (en) * | 2000-10-25 | 2002-07-18 | Mayo Foundation For Medical Education And Research | Transcobalamin binding conjugates useful for treating abnormal cellular proliferation |
| AU2002322275A1 (en) * | 2001-06-20 | 2003-01-08 | Mayo Foundation For Medical Education And Research | Adenosyl-cobalamin fortified compositions |
| US20060074034A1 (en) * | 2001-09-17 | 2006-04-06 | Collins Douglas A | Cobalamin mediated delivery of nucleic acids, analogs and derivatives thereof |
| US20030144198A1 (en) * | 2001-09-28 | 2003-07-31 | Collins Douglas A. | Coadministration of transport protein with conjugated cobalamin to deliver agents |
| KR100440725B1 (ko) * | 2002-06-20 | 2004-07-15 | 주식회사 그린진 바이오텍 | 비생물성 스트레스에 대한 단자엽 식물의 내성을증가시키는 방법 |
| WO2007008232A2 (en) * | 2004-09-03 | 2007-01-18 | Board Of Regents, The University Of Texas System | Locoregional internal radionuclide ablation of abnormal tissues. |
| US7419654B2 (en) * | 2004-10-08 | 2008-09-02 | Mrinal K. Dewanjee | Charge neutral complexes of paramagnetic metals as intracellular magnetic resonance imaging contrast agents |
| US8535750B2 (en) * | 2005-05-17 | 2013-09-17 | Cargill, Incorporated | Granular lecithins, granular lysolecithins, process for their production and compositions containing them |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US421452A (en) * | 1890-02-18 | Island | ||
| US4898724A (en) * | 1984-06-04 | 1990-02-06 | The Dow Chemical Company | Organis amine phosphonic acid complexes for the treatment of calcific tumors |
| DE3577550D1 (de) * | 1984-09-21 | 1990-06-13 | Dow Chemical Co | Aminocarbonsaeurekomplexe zur behandlung von knochentumoren. |
| US4897254A (en) * | 1984-09-21 | 1990-01-30 | The Dow Chemical Company | Radioactive compositions for the treatment of calcific tumors |
| NZ222304A (en) * | 1987-05-18 | 1990-10-26 | Dow Chemical Co | Suppression of bone marrow using samarium-153, gadolinium-159 or holmium-166 complexes |
-
1991
- 1991-01-30 US US07/648,663 patent/US5308606A/en not_active Expired - Lifetime
-
1992
- 1992-01-29 IL IL10080092A patent/IL100800A/en not_active IP Right Cessation
- 1992-01-29 AU AU10543/92A patent/AU650944B2/en not_active Ceased
- 1992-01-30 FI FI924363A patent/FI924363L/fi unknown
- 1992-01-30 JP JP92506262A patent/JPH05505629A/ja not_active Ceased
- 1992-01-30 DE DE69232554T patent/DE69232554T2/de not_active Expired - Fee Related
- 1992-01-30 MX MX9200413A patent/MX9200413A/es not_active IP Right Cessation
- 1992-01-30 NZ NZ241463A patent/NZ241463A/xx unknown
- 1992-01-30 ZA ZA92663A patent/ZA92663B/xx unknown
- 1992-01-30 IE IE031192A patent/IE920311A1/en unknown
- 1992-01-30 TW TW081100713A patent/TW205509B/zh active
- 1992-01-30 SG SG1996004830A patent/SG45366A1/en unknown
- 1992-01-30 WO PCT/US1992/000683 patent/WO1992013571A1/en active Application Filing
- 1992-01-30 AT AT92101569T patent/ATE216266T1/de not_active IP Right Cessation
- 1992-01-30 CA CA002060332A patent/CA2060332A1/en not_active Abandoned
- 1992-01-30 EP EP92101569A patent/EP0499098B1/en not_active Expired - Lifetime
- 1992-09-29 KR KR1019920702364A patent/KR100219965B1/ko not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| AU650944B2 (en) | 1994-07-07 |
| FI924363A7 (fi) | 1992-09-29 |
| SG45366A1 (en) | 1998-01-16 |
| TW205509B (forum.php) | 1993-05-11 |
| AU1054392A (en) | 1992-08-06 |
| FI924363A0 (fi) | 1992-09-29 |
| NZ241463A (en) | 2000-01-28 |
| US5308606A (en) | 1994-05-03 |
| ZA92663B (en) | 1993-07-30 |
| KR100219965B1 (ko) | 1999-09-01 |
| EP0499098B1 (en) | 2002-04-17 |
| IE920311A1 (en) | 1992-07-29 |
| EP0499098A2 (en) | 1992-08-19 |
| WO1992013571A1 (en) | 1992-08-20 |
| CA2060332A1 (en) | 1992-07-31 |
| FI924363L (fi) | 1992-09-29 |
| KR930700163A (ko) | 1993-03-13 |
| JPH05505629A (ja) | 1993-08-19 |
| DE69232554T2 (de) | 2002-08-08 |
| IL100800A (en) | 1996-10-31 |
| IL100800A0 (en) | 1992-09-06 |
| DE69232554D1 (de) | 2002-05-23 |
| MX9200413A (es) | 1992-08-01 |
| EP0499098A3 (en) | 1992-08-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE216266T1 (de) | Einen liganden enthaltendes arzneimittel zur behandlung und/oder diagnose von weichgeweben- tumoren | |
| ATE79264T1 (de) | Verwendung von bismuth zur herstellung von medikamenten zur behandlung von magendarmst¯rungen, die von campylobacter polyridis verursacht sind. | |
| DE3856594D1 (de) | Mittel zur behandlung der alzheimer-krankheit | |
| IT8027029A0 (it) | Complessi platino-diamminici e formulazioni farmaceutiche per il trattamento del cancro che licontengono. | |
| DE3888273D1 (de) | Medizinischer Apparat zur Behandlung mit Ultraschall. | |
| DE58908452D1 (de) | Medizinisches Gerät zur Diagnose und/oder Therapie. | |
| ATE69956T1 (de) | Mittel fuer die diagnose, die abbildung, die lokalisierung oder die behandlung von tumoren. | |
| ZA824983B (en) | Method for diagnosing and for the therapeutic treatment of tumors and/or infectious diseases of different types with alkaloid-compounds | |
| NO894222L (no) | Fremgangsmaater for behandling og profylakse av pneumocytis carinii pneumoni og andre sykdommer og forbindelser og formuleringer for anvendelse i nevnte metoder. | |
| EP0173663A3 (en) | The use of a specific tumor associated antigen, sialosyllactotetraose, in diagnostic or therapeutic procedures related to cancer deseases | |
| Frattola et al. | Multicenter clinical comparison of the effects of choline alfoscerate and cytidine diphosphocholine in the treatment of multi-infarct dementia. | |
| EP0280135A3 (en) | Protein c-inhibitor (pci) as a pharmaceutical and diagnostic agent, process for the preparation of such a pharmaceutical or diagnostic agent and a composition containing pci | |
| Karim et al. | Pulmonary fibrosis after prolonged treatment with low-dose cyclophosphamide. A case report | |
| JPS51118841A (en) | A drug for improving and treating clouding of consciousness | |
| GR880100589A (en) | Metalloporfyrines for the inversion of the toxic activity for the tumors treatment | |
| RU94024335A (ru) | Способ лечения рака молочной железы | |
| ATE66815T1 (de) | Arzneimittel enthaltend einen aus den peyer'schen plaques hergestellten organextrakt zur behandlung bei diabetes mellitus und pankreatitis. | |
| Albee | Silver and golden comments on Dr. Derner. | |
| FR2556958B1 (fr) | Appareil de detection, diagnostic et soins suivant l'acupuncture magnetique et bio-magnetique | |
| ATE36333T1 (de) | Hydantoin enthaltende therapeutische mittel. | |
| MX9200414A (es) | Metodo y composiciones para tumores de tejido blando | |
| Simpson | Towards a clinical pharmacology of truth: Working with the cancer patient; therapeutic uses of truth. | |
| Jackson | The treatment of anorectal carcinoma by interstitial Curietherapy | |
| RO76345A3 (ro) | Medicament complex utilizabil in tratamentul sechelelor radioterapieisi cheloidelor chirurgicale | |
| NO883040L (no) | Middel for undersoekelse av tumorer, samt fremgangsmaate for fremstilling av et slikt middel. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |